G. Vasse (Groningen, Netherlands), N. Mansouri (Lausanne, Switzerland)
Introduction
G. Vasse (Groningen, Netherlands), N. Mansouri (Lausanne, Switzerland)
|  |
Blood monocyte subsets to characterize and differentiate active SARS-CoV-2 infection from convalescent patients
E. Rutkowska (Warsaw, Poland), I. Kwiecien (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), K. Klos (Warsaw, Poland), A. Chcialowski (Warsaw, Poland)
|    |
Increased CD14+ monocytes and OPN+ positive airway macrophages in the BAL are associated with Post-COVID-19 induced altered respiratory function.
E. Tsitoura (Heraklion (Crete), Greece), E. Lambiri (Heraklion (Crete), Greece), S. Mastrodemou (Heraklion (Crete), Greece), D. Zevla (Heraklion (Crete), Greece), E. Bibaki (Heraklion (Crete), Greece), N. Bizymi (Heraklion (Crete), Greece), N. Tzanakis (Heraklion (Crete), Greece), K. Antoniou (Heraklion (Crete), Greece)
| |
The role of reactive nitrogen species as biomarkers of disease severity in COVID-19
N. Konyalilar (Istanbul, Turkey), Ö. Kayalar (Istanbul, Turkey), D. Mortazavi (Istanbul, Turkey), H. Rajabi (Istanbul, Turkey), S. Korkunç (Istanbul, Turkey), S. Erkan (Istanbul, Turkey), T. Aksoy (Istanbul, Turkey), M. Gönenli (Istanbul, Turkey), F. Tokgöz Akyil (Istanbul, Turkey), S. Altin (Istanbul, Turkey), H. Bayram (Istanbul, Turkey)
| |
Covid-19 and NETs
P. Ruiz De Gopegui (Zaragoza, Spain), S. Bello Dronda (Zaragoza, Spain), L. López Vergara (Zaragoza, Spain), L. Torralba Garcia (Zaragoza, Spain), C. De Diego Ramos (Zaragoza, Spain), C. Abadía Molina (Zaragoza, Spain), R. Lahoz Alonso (Zaragoza, Spain), A. Lasierra Monclus (Huesca, Spain), A. Cebollada Solanas (Zaragoza, Spain), J. Godino (Zaragoza, Spain), B. Jimeno Beltran (Zaragoza, Spain)
| |
To estimate oxidative stress and DNA damage in post-COVID patients.
S. Kant (Lucknow (Uttar Pradesh), India), N. Dikshit (Lucknow (Uttar Pradesh), India), A. Verma (Lucknow (Uttar Pradesh), India), K. Ansari (Lucknow (Uttar Pradesh), India), J. Bajpai (Lucknow (Uttar Pradesh), India), C. Kaur (Lucknow (Uttar Pradesh), India), I. Jahan (Lucknow (Uttar Pradesh), India)
| |
COVID-19 neutrophils show elevated migration and NETosis, which is reduced by PI3K inhibition
K. Belchamber (Birmingham, United Kingdom), S. Thein (Birmingham, United Kingdom), J. Hazeldine (Birmingham, United Kingdom), F. Grudzinska (Birmingham, United Kingdom), M. Hughes (Birmingham, United Kingdom), A. Jasper (Birmingham, United Kingdom), K. Yip (Birmingham, United Kingdom), L. Crowley (Birmingham, United Kingdom), S. Lugg (Birmingham, United Kingdom), E. Sapey (Birmingham, United Kingdom), D. Parekh (Birmingham, United Kingdom), D. Thickett (Birmingham, United Kingdom), A. Scott (Birmingham, United Kingdom), S. Thein (Birmingham (West Midlands), United Kingdom)
| |
Insights into the lung microenvironment after severe COVID-19
V. Vaira (Milan, Italy), A. Storaci (Milan, Italy), M. Pitasi (Milan, Italy), F. Gentile (Milan, Italy), F. Blasi (Milan, Italy), L. Morlacchi (Milan, Italy), A. Pesenti (Milan, Italy), G. Grasselli (Milan, Italy), P. Tagliabue (Milan, Italy), M. Clerici (Milan, Italy), F. Malvestiti (Milan, Italy), L. Valenti (Milan, Italy), S. Aliberti (Milan, Italy), R. Gualtierotti (Milan, Italy), S. Ferrero (Milan, Italy), M. Nosotti (Milan, Italy), A. Bandera (Milan, Italy), A. Gori (Milan, Italy), F. Peyvandi (Milan, Italy), S. Bosari (Milan, Italy), A. Palleschi (Milan, Italy)
| |
Molecular signatures of SARS-CoV2 in vitro infection of bronchial epithelium from CF, COPD and healthy subjects
L. Guillot (Paris, France), J. Oliva (Lyon, France), M. Ruffin (Paris, France), C. Calmel (Paris, France), H. Corvol (Paris, France), O. Terrier (Lyon, France)
| |
Late Breaking Abstract - mRNA vaccine boosts the SARS-CoV-2 specific mucosal antibody in recipients of inactivated and mRNA vaccines
S. Liu (HONG KONG, China), K. Chan (HONG KONG, China), Y. Wei (HONG KONG, China), R. Chan (HONG KONG, China)
| |